| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/20/2007 | US20070218465 Therapeutic Applications of Aminolevulinate Synthase |
| 09/20/2007 | US20070218451 Peroxisome-proliferator activated receptor-alpha agonists for organ preservation |
| 09/20/2007 | US20070218189 Reduction inhibitory agent for active oxygen eliminating-activity |
| 09/20/2007 | US20070218147 Peroxisome Proliferator-Activated Receptor (Ppar) Activator, and Drugs, Supplements, Functional Foods and Food Additives Using the Same |
| 09/20/2007 | US20070218143 Topical preparation |
| 09/20/2007 | US20070218141 Simvastatin compositions |
| 09/20/2007 | US20070218140 Slow-Release Preparations And Their Method Of Production |
| 09/20/2007 | US20070218137 Sustained release matrix systems for highly soluble drugs |
| 09/20/2007 | US20070218136 New mandelic acid derivatives and their use as thrombin inhibitors |
| 09/20/2007 | US20070218134 Compositions Comprising Organic Compounds |
| 09/20/2007 | US20070218130 Bisphosphonate composition and process for the preparation thereof |
| 09/20/2007 | US20070218129 Solid Dispersible and/or Orodispersible Non-Filmy Containing at Least One Type of Active Substance Pharmaceutical Composition and Method for the Preparation Thereof |
| 09/20/2007 | US20070218128 Manufacturing of Quick Release Pharmaceutical Compositions of Water Insoluble Drugs and Pharmaceutical Compositions Obtained By the Process of the Invention |
| 09/20/2007 | US20070218124 Nontoxic, biocompatible water in oil emulsion with organic phase of ethenically unsaturated monomers or oligomers that does not provoke an autoimmune or inflammatory response for reforming damaged or diseased intervertebral discs by noninvasive means |
| 09/20/2007 | US20070218121 Compounds that inhibit caspase activity for treating glaucoma |
| 09/20/2007 | US20070218119 Sterol enriched mixed lammelarity amphotericin intercalating liposomes in saline and the process for their preparation |
| 09/20/2007 | US20070218118 Methods and compositions for treating post- myocardial infarction damage |
| 09/20/2007 | US20070218117 Supra molecular construct for delivery of interferon to a mammal |
| 09/20/2007 | US20070218116 Compositions and methods for the treatment of tumors and tumor metastases |
| 09/20/2007 | US20070218112 Agent and food for preventing / improving functional digestive disorder |
| 09/20/2007 | US20070218109 Nutrient composition and composition for prevention/mitigation of digestive tract depression |
| 09/20/2007 | US20070218106 Alcohol Metabolism Moderating Composition |
| 09/20/2007 | US20070218104 Rate controlled release of a pharmaceutical agent in a biodegradable device |
| 09/20/2007 | US20070218103 Rate controlled release of a pharmaceutical agent in a biodegradable device |
| 09/20/2007 | US20070218093 Applicator and Method for Applying Lanolin to a Sore Nipple |
| 09/20/2007 | US20070218077 Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response |
| 09/20/2007 | US20070218076 Method of Processing Seaweed |
| 09/20/2007 | US20070218073 Antigenic composition |
| 09/20/2007 | US20070218072 Methods of improving health-related quality of life in individuals with systemic lupus erythematosus |
| 09/20/2007 | US20070218067 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors |
| 09/20/2007 | US20070218062 Methods of treating lupus using CD4 antibodies |
| 09/20/2007 | US20070218057 Human Obesity Susceptibility Gene and Uses Thereof |
| 09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
| 09/20/2007 | US20070218044 Decomposition and modification of silicate and silicone by silicase and use of the reversible enzyme |
| 09/20/2007 | US20070218042 Vitamins B2, B6, B12, Mg, glucosamine sulfate, dimethylsulfone, and chondroitin sulfate; thromboxane B2 antagonist; migraines, arthritis, fibromyalgia |
| 09/20/2007 | US20070218038 Stabilized, sterilized collagen scaffolds with active adjuncts attached |
| 09/20/2007 | US20070218034 Methods of using HCN genes to treat cardiac arrhythmias |
| 09/20/2007 | US20070218030 Dietetic Preparation for Prevention and Treatment of Osteoporosis |
| 09/20/2007 | US20070218029 High-deposition compositions and uses thereof |
| 09/20/2007 | US20070218016 Use of Aroma Substance Mixtures as Agents Against Bad Breath |
| 09/20/2007 | US20070218011 Aerosol Formulation Comprising Formoterol in Suspension |
| 09/20/2007 | DE20321512U1 Zusammensetzung zur Erleichterung der Humangeburt Composition to facilitate human childbirth |
| 09/20/2007 | DE20321510U1 Kolonreinigungszusammensetzungen Kolonreinigungszusammensetzungen |
| 09/20/2007 | DE202006012340U1 Pharmazeutische Zusammensetzung, insbesondere zur Anwendung bei Nahrungsmittelunverträglichkeiten A pharmaceutical composition, in particular for use in food intolerances |
| 09/20/2007 | DE19882435B4 Verfahren zur Hemmung von Krebszellwachstum mit einem pRb2/p130 exprimierenden Vektor Methods of inhibiting cancer cell growth with a pRb2 / p130 expressing vector |
| 09/20/2007 | DE10216719B4 N-(3-Rifamycinyl)carbamate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Behandlung und Verhütung von Tuberkulose N- (3-Rifamycinyl) carbamates, process for their preparation and their use in the treatment and prevention of tuberculosis |
| 09/20/2007 | DE102006042516A1 Verringerung eines Risikos für allerg. Reducing risk for Allergic Rhinitis. und Überempfindlichkeitsreaktionen bei Applikation des Arzneimittels Tobramycin Injektions- bzw. Infusionslösung aufgrund einer Natriummetabisulfitfreien Darreichungsform and hypersensitivity reactions in application of the drug tobramycin injection or infusion solution due to a dosage form Natriummetabisulfitfreien |
| 09/20/2007 | DE102006013431A1 Haarwuchsmittel Hair restorer |
| 09/20/2007 | DE102006012548A1 Substituierte Chromanol-Derivate und ihre Verwendung Substituted chromanol derivatives and their use |
| 09/20/2007 | DE102005038803A1 Verfahren zur Herstellung von 5-Aryl-Nicotinsäureamiden Process for the preparation of 5-aryl-Nicotinsäureamiden |
| 09/20/2007 | CA2717249A1 Dibenzyl amine compounds and derivatives |
| 09/20/2007 | CA2717242A1 Dibenzyl amine derivatives as cetp inhibitors |
| 09/20/2007 | CA2657932A1 Stable lozenge compositions providing rapid release of nicotine |
| 09/20/2007 | CA2647031A1 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
| 09/20/2007 | CA2646942A1 Improved snuff composition |
| 09/20/2007 | CA2646516A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors) |
| 09/20/2007 | CA2646447A1 Agent-enriched nanoparticles based on hydrophilic proteins |
| 09/20/2007 | CA2646438A1 Methods and compositions for treatment of diastolic heart failure |
| 09/20/2007 | CA2646430A1 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| 09/20/2007 | CA2646336A1 Diphenylurea derivatives and their use as chloride channel blockers or bkca channel modulators |
| 09/20/2007 | CA2646316A1 Methods of treating muscular wasting diseases using nf-kb activation inhibitors |
| 09/20/2007 | CA2646256A1 Amino acid derivatives |
| 09/20/2007 | CA2646235A1 Non-peptidic renin inhibitors nitroderivatives |
| 09/20/2007 | CA2646230A1 Chewing gum compositions providing rapid release of nicotine |
| 09/20/2007 | CA2646223A1 Novel heterocyclic nf-kb inhibitors |
| 09/20/2007 | CA2646154A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 09/20/2007 | CA2646023A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
| 09/20/2007 | CA2645810A1 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement |
| 09/20/2007 | CA2645809A1 Peptidomimetic inhibitors of psma, compounds comprising them, and methods of use |
| 09/20/2007 | CA2645765A1 Ophthalmic compositions comprising povidone-iodine |
| 09/20/2007 | CA2645712A1 Triazole derivative or salt thereof |
| 09/20/2007 | CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | CA2645629A1 Orodispersible domperidone tablets |
| 09/20/2007 | CA2645617A1 Compositions and methods for immunisation using cd1d ligands |
| 09/20/2007 | CA2645456A1 Photoactive compounds and compositions and uses thereof |
| 09/20/2007 | CA2645376A1 Aminoquinolones as gsk-3 inhibitors |
| 09/20/2007 | CA2645350A1 Novel bis-2-difluoro-pyrrolo[2,1-c][1,4]benzodiazepine dimmers |
| 09/20/2007 | CA2645343A1 Pyrrolopyrimidine derivatives used as hsp90 inhibitors |
| 09/20/2007 | CA2645340A1 Topical compositions in the form of an oil-in-water emulsion comprising a pro-penetrating glycol and a steroidal anti-inflammatory drug |
| 09/20/2007 | CA2645339A1 Topical compositions in the form ofan oil-in-water emulsion comprising a pro-penetrant glycol and a steroidal anti-inflammatory drug |
| 09/20/2007 | CA2645311A1 Aqueous composition comprising 15-keto-prostaglandin for ophthalmic use |
| 09/20/2007 | CA2645289A1 Pyridine-containing macroheterocylic compounds as kinase inhibitors |
| 09/20/2007 | CA2645063A1 Porphyrin derivates and their use as photosensitizers in photodynamic therapy |
| 09/20/2007 | CA2644917A1 Fluorinated carbohydrates and their use in tumor visualization, tissue engineering, and cancer chemotherapy |
| 09/20/2007 | CA2644784A1 Formulations of sitaxsentan sodium |
| 09/20/2007 | CA2644694A1 Triggered self-assembly conjugates and nanosystems |
| 09/20/2007 | CA2644561A1 Fluidic tissue augmentation compositions and methods |
| 09/20/2007 | CA2644389A1 Pharmaceutical combinations of hcv-protease and -ires inhibitors |
| 09/20/2007 | CA2644368A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | CA2644345A1 A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof. |
| 09/20/2007 | CA2644134A1 Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-[2-methyl-4,5-(methylenedioxy)phenylacetyl]thiophene-3-sulfonamide, sodium salt |
| 09/20/2007 | CA2644033A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 09/20/2007 | CA2644014A1 Bezothiazol derivatives as beta2 adrenoreceptor agonists |
| 09/20/2007 | CA2644010A1 Tetrahydroisoquinoline derivatives to enhance memory function |
| 09/20/2007 | CA2643962A1 Antibiotic compounds |
| 09/20/2007 | CA2643859A1 Soluble epoxide hydrolase inhibitors and methods of using same |
| 09/20/2007 | CA2643410A1 Substituted imidazo[2,1-b]thiazole compounds and their use for producing drugs |
| 09/20/2007 | CA2643222A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs |
| 09/20/2007 | CA2643209A1 Methods for increasing blood flow and/or promoting tissue regeneration |
| 09/20/2007 | CA2643070A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |